LiveForeverHealth announced the launch of a full-stack hormone and telemedicine franchise platform designed to expand access to integrated hormone therapy, metabolic health services and virtual care across the United States. The franchise model combines clinical services, telehealth delivery and proprietary protocols to support patient evaluation, hormone optimization and ongoing remote care.
According to the company, the LiveForeverHealth franchise will offer comprehensive endocrine care, including bioidentical hormone replacement therapy, metabolic assessments, personalized treatment plans and chronic disease management, all supported by an in-house telemedicine infrastructure. The platform aims to help practitioners deliver standardized, evidence-informed hormone services while scaling reach through digital visits and hybrid clinic operations.
LiveForeverHealth said its clinical protocols are built around patient safety, measurable outcomes and data-driven decision making. The franchise opportunity includes training, clinical guidance, technology integration and business support for franchisees to establish local hormone care practices linked with centralized telemedicine resources.
The company added that the model addresses rising demand for accessible hormone and wellness care, particularly among aging and metabolic-health focused populations. By aligning in-clinic and virtual care delivery, LiveForeverHealth plans to enhance continuity of care, support long-term patient engagement and extend specialist access to underserved or geographically dispersed communities.
LiveForeverHealth positions the franchise as part of a broader shift in healthcare toward integrated, patient-centric services that blend technology, personalized medicine and preventative health strategies. The firm said it will begin onboarding franchise partners in early 2026.
